Donor tissue is obtained through a next-of-kin first person consent program with FDA registered recovery agencies contracted with our production partner. These cadaveric donors undergo a series of pre-production serological and microbiological testing, coupled with an extensive eligibility and suitability determination by a medical director prior to release for implant.
In addition, the production partner conducts many in-process tests that are congruent with FDA Regulations 21 CFR 1270 and 1271. Every donor is screened for potential communicable diseases. These tests include, but are not always limited to the following serological tests: